Carumonam Enhances Reactivity of Escherichia Coli with Mono- and Polyclonal Antisera to Rough Escherichia Coli J5

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1987 Jun 1

PMID 2439534

Citations 8

Authors

B P Overbeek

J F Schellekens

W Lippe

B A Dekker

J Verhoef

Affiliations

Soon will be listed here.

Abstract

Escherichia coli O111 reacts only slightly with antiserum to its rough mutant E. coli J5 in an enzyme-linked immunosorbent assay. When E. coli O111 was grown in the presence of sub-MICs of the monocyclic beta-lactam antibiotic carumonam, however, the enzyme-linked immunosorbent assay titer increased from 1,280 to 81,920. When the bacteria were grown in the presence of carumonam, the titer that was obtained with antiserum against E. coli O111 was not affected. This reaction was abolished after this antiserum was absorbed with E. coli J5 in the case of the carumonam-treated strain, whereas this absorption did not affect the reaction with E. coli O111. Thus, the O-antigenic side chain of E. coli O111 seems to be affected if this strain is cultured in the presence of carumonam. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed a relative loss of the O polysaccharide in E. coli O111 when this strain was grown in the presence of carumonam. Also, a much stronger reaction of the antibiotic-affected lipopolysaccharide with a monoclonal antibody against E. coli J5 lipopolysaccharide was shown in immunoblots. The results of this study indicate that there is a synergism between certain antibiotics and monoclonal antibodies, something that could have clinical implications.

Citing Articles

Effects of sub-MICs of erythromycin and other macrolide antibiotics on serum sensitivity of Pseudomonas aeruginosa.

Tateda K, Hirakata Y, Furuya N, Ohno A, Yamaguchi K Antimicrob Agents Chemother. 1993; 37(4):675-80.

PMID: 8494362 PMC: 187733. DOI: 10.1128/AAC.37.4.675.

The anti-lipid A antibody HA-1A binds to rough gram-negative bacteria, fixes complement and facilitates binding to erythrocyte CR1 (CD35).

Tonoli M, Davies K, Norsworthy P, Cohen J, Walport M Clin Exp Immunol. 1993; 92(2):232-8.

PMID: 8485908 PMC: 1554794. DOI: 10.1111/j.1365-2249.1993.tb03385.x.

Reactivity of the human antiendotoxin immunoglobulin M monoclonal antibody HA-1A with lipopolysaccharides from rough and smooth gram-negative organisms.

Mascelli M, Frederick B, Ely T, Neblock D, Shealy D, Pak K Infect Immun. 1993; 61(5):1756-63.

PMID: 8478065 PMC: 280762. DOI: 10.1128/iai.61.5.1756-1763.1993.

Antibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria.

SIEGEL S, Evans M, Pollack M, Leone A, Kinney C, Tam S Infect Immun. 1993; 61(2):512-9.

PMID: 8423081 PMC: 302758. DOI: 10.1128/iai.61.2.512-519.1993.

Preincubation of Haemophilus influenzae with subinhibitory concentrations of macrolides: influence on human neutrophil chemiluminescence.

Bonnet M, Van der Auwera P Antimicrob Agents Chemother. 1993; 37(5):1015-24.

PMID: 8390808 PMC: 187883. DOI: 10.1128/AAC.37.5.1015.

References

Ziegler E, Douglas H, Sherman J, Davis C, BRAUDE A . Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant. J Immunol. 1973; 111(2):433-8. View

Bouter A, Marcelis J, Schellekens J, Verhoef J . Cross-reactivity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria. Eur J Clin Microbiol. 1986; 5(2):148-51. DOI: 10.1007/BF02013970. View

Kohler G, Milstein C . Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256(5517):495-7. DOI: 10.1038/256495a0. View

Johns M, Bruins S, McCabe W . Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants. Infect Immun. 1977; 17(1):9-15. PMC: 421074. DOI: 10.1128/iai.17.1.9-15.1977. View

BRAUDE A, Ziegler E, Douglas H, McCutchan J . Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia. J Infect Dis. 1977; 136 Suppl:S167-73. DOI: 10.1093/infdis/136.supplement.s167. View

GREISMAN S, DuBuy J, Woodward C . Experimental gram-negative bacterial sepsis: reevaluation of the ability of rough mutant antisera to protect mice. Proc Soc Exp Biol Med. 1978; 158(3):482-90. DOI: 10.3181/00379727-158-40231. View

Shulman M, Wilde C, Kohler G . A better cell line for making hybridomas secreting specific antibodies. Nature. 1978; 276(5685):269-70. DOI: 10.1038/276269a0. View

Washington 2nd J . The effects and significance of subminimal inhibitory concentrations of antibiotics. Rev Infect Dis. 1979; 1(5):781-6. DOI: 10.1093/clinids/1.5.781. View

Zak O, KRADOLFER F . Effects of subminimal inhibitory concentrations of antibiotics in experimental infections. Rev Infect Dis. 1979; 1(5):862-79. DOI: 10.1093/clinids/1.5.862. View

10.

de StGroth S, Scheidegger D . Production of monoclonal antibodies: strategy and tactics. J Immunol Methods. 1980; 35(1-2):1-21. DOI: 10.1016/0022-1759(80)90146-5. View

11.

Burnette W . "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981; 112(2):195-203. DOI: 10.1016/0003-2697(81)90281-5. View

12.

van Dijk W, Verbrugh H, Peters R, Verhoef J . Escherichia coli antibodies in opsonisation and protection against infection. J Med Microbiol. 1981; 14(4):381-9. DOI: 10.1099/00222615-14-4-381. View

13.

Peter G, Chernow M, Keating M, Ryff J, Zinner S . Limited protective effect of rough mutant antisera in murine Escherichia coli bacteremia. Infection. 1982; 10(4):228-32. DOI: 10.1007/BF01666916. View

14.

Ziegler E, McCutchan J, Fierer J, Glauser M, Sadoff J, Douglas H . Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med. 1982; 307(20):1225-30. DOI: 10.1056/NEJM198211113072001. View

15.

Nelles M, Niswander C . Mouse monoclonal antibodies reactive with J5 lipopolysaccharide exhibit extensive serological cross-reactivity with a variety of gram-negative bacteria. Infect Immun. 1984; 46(3):677-81. PMC: 261596. DOI: 10.1128/iai.46.3.677-681.1984. View

16.

Teng N, Kaplan H, Hebert J, Moore C, Douglas H, Wunderlich A . Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proc Natl Acad Sci U S A. 1985; 82(6):1790-4. PMC: 397358. DOI: 10.1073/pnas.82.6.1790. View

17.

Gigliotti F, Shenep J . Failure of monoclonal antibodies to core glycolipid to bind intact smooth strains of Escherichia coli. J Infect Dis. 1985; 151(6):1005-11. DOI: 10.1093/infdis/151.6.1005. View

18.

Baumgartner J, Glauser M, McCutchan J, Ziegler E, van Melle G, Klauber M . Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. Lancet. 1985; 2(8446):59-63. DOI: 10.1016/s0140-6736(85)90176-x. View

19.

Imada A, Kondo M, OKONOGI K, Yukishige K, Kuno M . In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic. Antimicrob Agents Chemother. 1985; 27(5):821-7. PMC: 180159. DOI: 10.1128/AAC.27.5.821. View

20.

Then R, Kohl I . Affinity of carumonam for penicillin-binding proteins. Chemotherapy. 1985; 31(4):246-54. DOI: 10.1159/000238343. View